FDA Silicone Breast Implant Review Moves Forward, Despite CoI Objections
This article was originally published in The Gray Sheet
Executive Summary
Michael Miller's contributions to the FDA General & Plastic Surgery Devices Panel's recent silicone-filled breast implant review outweigh any alleged conflict of interest, the agency maintains